✦ LIBER ✦

Current overview of the genetic background of atrial fibrillation: Possible therapeutic gene targets for the treatment of atrial fibrillation

✍ Scribed by Tetsushi Furukawa; Yusuke Ebana

Book ID: 119304925
Publisher: Wiley (John Wiley & Sons)
Year: 2012
Tongue: English
Weight: 383 KB
Volume: 28
Category: Article
ISSN: 1880-4276
DOI: 10.1016/j.joa.2012.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atrial-Selective Approaches for the Trea

Atrial-Selective Approaches for the Treatment of Atrial Fibrillation

✍ Joachim R. Ehrlich; Peter Biliczki; Stefan H. Hohnloser; Stanley Nattel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Current Status of the Surgical Treatment

Current Status of the Surgical Treatment of Atrial Fibrillation

✍ Alexander S. Geha; Khaled Abdelhady 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 177 KB

Association of the human minK gene 38G a

Association of the human minK gene 38G allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation

✍ Ling-Ping Lai; Ming-Jai Su; Huei-Ming Yeh; Jiunn-Lee Lin; Fu-Tien Chiang; Juey-J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Dronedarone for the Treatment of Atrial

Dronedarone for the Treatment of Atrial Fibrillation

✍ McKenna, Claire; Maund, Emma; Sarowar, Muhammad; Fox, David; Stevenson, Matt; Pe 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 184 KB

Novel Antiarrhythmic Drugs for the Treat

Novel Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation: Current Perspective

✍ Nakaya, Haruaki 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 76 KB

Inflammatory pathways as targets for the

Inflammatory pathways as targets for the treatment and prevention of atrial fibrillation

✍ David R. Van Wagoner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB